TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/22/2025
Back to search
Official data from USPTO
AMPHISTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMPHISTA
ST13
US500000097409699Class
1, 5, 42
Filing
97409699
Registration
7172943
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/27/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
05/13/2022
Registration date
09/26/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
04/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
11
Owner location
Zurich, CH
Examiner
BRACEY, KAREN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Amphista Therapeutics Limited
Amphista Therapeutics Limited
Representatives
Rob LeBlanc Greenberg Traurig, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or research use; with none of the above for use in the field of agriculturehorticultureforestryagronomy or the home and garden sector
Class 5
Pharmaceuticalsmedicinal and veterinary preparations for the diagnosis and treatment of damaged tissuedermatological diseases and disordersinfectious diseasespainobesitycognitive disordersinflammationviral diseases and disordersneurological diseases and disordersendocrine diseases and disordersmetabolic diseases and disordersgenitourinary diseases and disordersmusculoskeletal diseases and disorderscardiovascular diseases and disorderscardiopulmonary diseases and disordersoncological diseases and disordersrespiratory diseases and disordershepatological diseases and disordersgastrointestinal diseases and disorderspsychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissuedermatological diseases and disordersinfectious diseasespainobesitycognitive disordersinflammationviral diseases and disordersneurological diseases and disordersendocrine diseases and disordersmetabolic diseases and disordersgenitourinary diseases and disordersmusculoskeletal diseases and disorderscardiovascular diseases and disorderscardiopulmonary diseases and disordersoncological diseases and disordersrespiratory diseases and disordershepatological diseases and disordersgastrointestinal diseases and disorderspsychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for use in diagnosis and treatment of damaged tissuedermatological diseases and disordersinfectious diseasespainobesitycognitive disordersinflammationviral diseases and disordersneurological diseases and disordersendocrine diseases and disordersmetabolic diseases and disordersgenitourinary diseases and disordersmusculoskeletal diseases and disorderscardiovascular diseases and disorderscardiopulmonary diseases and disordersoncological diseases and disordersrespiratory diseases and disordershepatological diseases and disordersgastrointestinal diseases and disorderspsychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; with none of the above for use in the field of agriculturehorticultureforestryagronomy or the home and garden sector
Class 42
Scientific and technological servicesscientific analysistestingengineeringdevelopmentresearch and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medical preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological and chemical testing; research and development in the pharmaceuticalchemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; with none of the above for use in the field of agriculturehorticultureforestryagronomy or the home and garden sector
Publications
History of USPTO decisions and trademark events.
33 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/22/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/22/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/07/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/03/2023
GNRT
NON-FINAL ACTION E-MAILED
03/03/2023
CNRT
NON-FINAL ACTION WRITTEN
03/03/2023
DOCK
ASSIGNED TO EXAMINER
03/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/15/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/15/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/15/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/14/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/14/2023
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
06/02/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2022
NWAP
NEW APPLICATION ENTERED
05/17/2022
Continuous trademark protection
Get notified about every new filing that threatens AMPHISTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.